# Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction

> **NCT00977587** · NA · WITHDRAWN · sponsor: **University of Nottingham**

## Conditions studied

- Irritable Bowel Syndrome
- Post Infective Bowel Dysfunction

## Interventions

- **DRUG:** Saccharomyces Cerevisiae CNCM I-3856
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00977587
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to get MHRA approval for formulation in present form
- **Last updated:** 2017-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977587, "Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00977587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*